日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)

HIV包膜三聚体免疫原的安全性和免疫原性,该免疫原可诱导CD4结合位点中和抗体前体(HVTN 300)

Walsh, Stephen R; Hahn, William O; Williams, Wilton B; Hyrien, Ollivier; Yu, Pei-Chun; Parks, K Rachael; Edwards, Robert J; Parks, Rob; Barr, Maggie; Polakowski, Laura L; Tindale, India; Jones, Megan; Yurdadon, Claudio; Burnham, Randy; Yeh, Chen-Hao; Heptinstall, Jack; Seaton, Kelly E; Andriesen, Jessica G; Sagawa, Zachary; Miner, Maurine D; De Rosa, Steve; McElrath, M Juliana; Corey, Lawrence; Tomaras, Georgia D; Montefiori, David C; Haynes, Barton F; Mayer, Kenneth H; Baden, Lindsey R

Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection.

慢性移植排斥反应会破坏人类肾脏淋巴系统的器官特异性特征

Jafree Daniyal J, Stewart Benjamin J, Price Karen L, Kolatsi-Joannou Maria, Laroche Camille, Mohidin Barian, Davis Benjamin, Mitchell Hannah, Russell Lauren G, Del Rey Lucía Marinas, Wang Chun Jing, Mason William J, Lee Byung Il, Heptinstall Lauren, Subramanian Ayshwarya, Pomeranz Gideon, Moulding Dale, Wilson Laura, Wickenden Tahmina, Malik Saif N, Holroyd Natalie, Walsh Claire L, Chandler Jennifer C, Cao Kevin X, Winyard Paul Jd, Woolf Adrian S, Busche Marc Aurel, Walker-Samuel Simon, Walker Lucy Sk, Crompton Tessa, Scambler Peter J, Motallebzadeh Reza, Clatworthy Menna R, Long David A

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

在美国,一项首次人体I期随机试验,旨在评估V2特异性HIV-1广谱中和抗体PGDM1400LS在未感染HIV-1的人群中静脉或皮下输注的安全性、药代动力学和中和活性(HVTN 140/HPTN 101 A部分):一项首次人体试验。

Seaton, Kelly E; Paez, Carmen A; Yu, Chenchen; Karuna, Shelly T; Gamble, Theresa; Miner, Maurine D; Heptinstall, Jack; Zhang, Lu; Gao, Fei; Yacovone, Margaret; Spiegel, Hans; Dumond, Julie B; Anderson, Maija; Piwowar-Manning, Estelle; Dye, Bonnie; Tindale, India; Proulx-Burns, Lori; Trahey, Meg; Takuva, Simbarashe; Takalani, Azwidihwi; Bailey, Veronique C; Kalams, Spyros A; Scott, Hyman; Mkhize, Nonhlanhla N; Weiner, Joshua A; Ackerman, Margaret E; McElrath, M Juliana; Pensiero, Michael; Barouch, Dan H; Montefiori, David; Tomaras, Georgia D; Corey, Lawrence; Cohen, Myron S; Huang, Yunda; Mahomed, Sharana; Siegel, Marc; Kelley, Colleen F

Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320

对“在出生时被指定为女性的南部非洲人群中评估嵌合型 HIV-1 疫苗方案的 Imbokodo (HVTN 705/HPX2008) 疗效试验的免疫相关性分析:一项两阶段病例对照研究”的更正。EBioMedicine 2024;108: 105320

Kenny, Avi; van Duijn, Janine; Dintwe, One; Heptinstall, Jack; Burnham, Randy; Sawant, Sheetal; Zhang, Lu; Mielke, Dieter; Khuzwayo, Sharon; Omar, Faatima Laher; Stanfield-Oakley, Sherry; Keyes, Taylor; Dunn, Brooke; Goodman, Derrick; Fong, Youyi; Benkeser, David; Zou, Rodger; Hural, John; Hyrien, Ollivier; Juraska, Michal; Luedtke, Alex; van der Laan, Lars; Giorgi, Elena E; Magaret, Craig; Carpp, Lindsay N; Pattacini, Laura; van de Kerkhof, Tom; Korber, Bette; Willems, Wouter; Fisher, Leigh H; Schuitemaker, Hanneke; Swann, Edith; Kublin, James G; Pau, Maria G; Buchbinder, Susan; Tomaka, Frank; Nijs, Steven; Lavreys, Ludo; Gelderblom, Huub C; Corey, Lawrence; Mngadi, Kathryn; Gray, Glenda E; Borducchi, Erica; Hendriks, Jenny; Seaton, Kelly E; Zolla-Pazner, Susan; Barouch, Dan H; Ferrari, Guido; De Rosa, Stephen C; McElrath, M Juliana; Andersen-Nissen, Erica; Stieh, Daniel J; Tomaras, Georgia D; Gilbert, Peter B

Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV

对一种广谱中和HIV的单克隆抗体VRC07-523LS进行药代动力学相互作用评估:一项纳入三项I期临床试验的非HIV感染者交叉方案分析

Chawana, Tariro D; Walsh, Stephen R; Stranix-Chibanda, Lynda; Chirenje, Zvavahera M; Yu, Chenchen; Zhang, Lily; Seaton, Kelly E; Heptinstall, Jack; Zhang, Lu; Paez, Carmen A; Gamble, Theresa; Karuna, Shelly T; Andrew, Philip; Hanscom, Brett; Sobieszczyk, Magdalena E; Edupuganti, Srilatha; Gay, Cynthia L; Mannheimer, Sharon B; Hurt, Christopher B; Stephenson, Kathryn E; Polakowski, Laura L; Spiegel, Hans; Yacovone, Margaret; Regenold, Stephanie; Yen, Catherine; Baumblatt, Jane Ag; Gama, Lucio; Barouch, Dan H; Piwowar-Manning, Estelle; Koup, Richard A; Tomaras, Georgia D; Hyrien, Ollivier; Roxby, Alison C; Huang, Yunda

Dietary Breadth Predicts Toxin Expression Complexity in the Venoms of North American Gartersnakes

北美束带蛇毒液中毒素表达的复杂性与食物种类密切相关

Heptinstall, T C; Rosales García, R A; Rautsaw, R M; Myers, E A; Holding, M L; Mason, A J; Hofmann, E P; Schramer, T D; Hogan, M P; Borja, M; Castañeda-Gaytán, G; Feldman, C R; Rokyta, D R; Parkinson, C L

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

在13项HIV疫苗试验中,采用多价DNA启动疫苗联合匹配的多价蛋白/GLA-SE加强免疫方案,诱导出了最强效、最广泛的IgG和IgG3 V1V2结合抗体以及CD4+ T细胞反应。

Moodie, Zoe; Li, Shuying Sue; Giorgi, Elena E; Williams, LaTonya D; Dintwe, One; Carpp, Lindsay N; Chen, Shiyu; Seaton, Kelly E; Sawant, Sheetal S; Zhang, Lu; Heptinstall, Jack; Liu, Shuying; Grunenberg, Nicole; Tomaka, Frank; Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayaphan, Sorachai; Ake, Julie A; Vasan, Sandhya; Pantaleo, Giuseppe; Frank, Ian; Baden, Lindsey R; Goepfert, Paul A; Keefer, Michael; Chirenje, Mike; Hosseinipour, Mina C; Mngadi, Kathryn; Laher, Fatima; Garrett, Nigel; Bekker, Linda-Gail; De Rosa, Stephen; Andersen-Nissen, Erica; Kublin, James G; Lu, Shan; Gilbert, Peter B; Gray, Glenda E; Corey, Lawrence; McElrath, M Juliana; Tomaras, Georgia D

HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines

HVTN 123:一项比较稳定转染细胞系和瞬时转染细胞系产生的 CH505TF gp120 的安全性和免疫原性的 1 期随机试验

Wilson, Gregory J; Church, L W Preston; Kelley, Colleen F; Robinson, Samuel T; Lu, Yiwen; Furch, Briana D; Fong, Youyi; Paez, Carmen A; Yacovone, Margaret; Jacobsen, Thomas; Maughan, Maureen; Martik, Diana; Heptinstall, Jack R; Zhang, Lu; Montefiori, David C; Tomaras, Georgia D; Kublin, James G; Corey, Lawrence

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines

对ALVAC-HIV和二价C亚型gp120/MF59 HIV疫苗的性别差异免疫反应进行回顾性分析

Ackerley, Cassie G; Edupuganti, Srilatha; Yu, Chenchen; Roxby, Alison C; Seaton, Kelly E; Bekker, Linda-Gail; Allen, Mary; DeRosa, Stephen C; Yates, Nicole L; Heptinstall, Jack; Mkhize, Nonhlanhla N; Malahleha, Mookho; Mngadi, Kathryn; Daniels, Brodie; Innes, Craig; Furch, Briana D; Koutsoukos, Marguerite; Ferrari, Guido; Morris, Lynn; Montefiori, David C; McElrath, M Juliana; Tomaras, Georgia D; Laher, Fatima; Moodie, Zoe

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

在一项 I 期临床试验中,接种 mRNA 编码的膜锚定 HIV 包膜三聚体疫苗可诱导产生 2 级中和抗体。

Parks, K Rachael; Moodie, Zoe; Allen, Mary A; Yen, Catherine; Furch, Briana D; MacPhee, Kellie J; Ozorowski, Gabriel; Heptinstall, Jack; Hahn, William O; Zheng, Zihan; Lu, Huiyin; Grant, Shannon; Domin, Elize; Duff, Michael O; Seese, Aaron; Marini-Macouzet, Constanza; Ballweber-Fleming, Lamar; Lee, Wen-Hsin; Cottrell, Christopher A; Liguori, Alessia; Georgeson, Erik; Alavi, Nushin; Kubitz, Michael; Phelps, Nicole; Seaton, Kelly E; Cohen, Kristen W; Anderson, Maija A; Mondal, Kajari; Laufer, Dagna S; Kublin, James G; Ward, Andrew B; Hyrien, Ollivier; De Rosa, Stephen C; Himansu, Sunny; Leav, Brett; Reuter, Caroline; Tomaras, Georgia D; Montefiori, David; Walsh, Stephen R; Frank, Ian; Sobieszczyk, Magdalena E; Goepfert, Paul A; Stephenson, Kathryn E; Baden, Lindsey R; Van Tieu, Hong; Keefer, Michael C; Clark, Jesse; Riddler, Sharon A; Schief, William R; McElrath, M Juliana